PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-08-19

Date Title Company
19-Aug-2024 Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I AccessWire
19-Aug-2024 ADM Tronics Reports First Quarter of Fiscal Year 2025 Results AccessWire
19-Aug-2024 Empowering Confidence: Dr. Todd B. Koch's Mastery in Boosting Self-Esteem Through Plastic Surgery AccessWire
19-Aug-2024 DEFENCE INVESTIGATES THE APPLICATION OF THE ACCUM® HYDROGEL TECHNOLOGY TO DELIVER GLP-1 IN ORDER TO INCREASE THE TREATMENT EFFICACY OF DIABETES AND WEIGHT LOSS Defence Therapeutics Inc.
19-Aug-2024 Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) AccessWire
19-Aug-2024 Ombudsman warns of surge in maternity investigations England’s Health Ombudsman
19-Aug-2024 UK must get ready for new cell and gene therapies, says ABPI Advanced Therapy Medicinal Products (ATMPs),
19-Aug-2024 Supply chain resilience in pharma: Delivering consistency amidst global events Bachem
19-Aug-2024 Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety AccessWire
19-Aug-2024 Positive Results from Lexaria's Molecular Characterization Study AccessWire
19-Aug-2024 Sheila Savageau Joins the IntoValue Board of Directors AccessWire
19-Aug-2024 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG
19-Aug-2024 Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61% AccessWire
19-Aug-2024 MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End Newswire
19-Aug-2024 MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End AccessWire
19-Aug-2024 MindBio Announces Sustained Antidepressant Response 3-Months Post Treatment in Microdosing Depression Clinical Trials AccessWire
19-Aug-2024 Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi™ and FDA Accepts Biosimilar Biologics License Application for TX-05 Newswire
19-Aug-2024 uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy Newswire
19-Aug-2024 uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy AccessWire
19-Aug-2024 Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05 AccessWire